Sahil Sahni

5PUBLICATIONS
35CO-AUTHORS
Molecular targetsGenomics and transcriptomicsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 01, 2026
Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells.

Shruti V Bendre, Yu Wang, Basel Hajyousif

|Sep 29, 2025
Reusability report: Leveraging supervised learning to uncover phenotype-relevant biology from single-cell RNA sequencing data.

Yingying Cao, Tian-Gen Chang, Sahil Sahni

|Sep 01, 2025
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma.

Binbin Wang, Robert Saddawi-Konefka, Lauren M Clubb

|Oct 14, 2024
A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade.

Sahil Sahni, Binbin Wang, Di Wu

|Oct 02, 2024
ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency.

Ishtiaque Hossain, Pierre Priam, Sofia C Reynoso

Pageof 1

Frequent Collaborators

3 joint publications

Eytan Ruppin

2 joint publications

Saugato Rahman Dhruba

2 joint publications

Kun Wang

1 joint publications

Ishtiaque Hossain